The National Agency for Food and Drug Administration and Control (NAFDAC) has introduced advanced traceability Technology in Northwest Nigeria to combat substandard and falsified medicines. This initiative is part of the agency’s broader efforts to strengthen the pharmaceutical supply chain and enhance Public Health safety. By deploying a traceability system, NAFDAC aims to monitor the movement of pharmaceutical products from manufacturers to end-users, ensuring transparency and making it easier to detect and eliminate counterfeit drugs.
A major aspect of this initiative is GreenBook, a digital verification tool that enables both consumers and regulators to confirm the authenticity of pharmaceutical products instantly. Additionally, NAFDAC has introduced the Paediatric Regulation 2024, which focuses on ensuring that medicines for children meet strict safety and quality standards. Professor Mojisola Adeyeye, NAFDAC’s director-general, highlighted that the agency’s five-year traceability plan aligns with the Nigeria Pharmaceutical Traceability Strategy and is expected to enhance supply chain oversight while reinforcing efforts to eliminate substandard medical products.
Fake drugs remain a public health threat in Nigeria.
Beyond ensuring drug authenticity, the traceability system has broader implications for Nigeria’s healthcare sector. The proliferation of counterfeit medicines has long been a public health challenge, leading to treatment failures, drug resistance, and fatalities. Many Nigerians, particularly in rural areas, often unknowingly purchase fake drugs due to limited access to regulated pharmacies. With digital verification tools like GreenBook, consumers can now check the authenticity of medicines before use, reducing the circulation of substandard products and reinforcing trust in the pharmaceutical industry. If widely adopted, this initiative could significantly lower health risks and improve treatment outcomes across the country.
Moreover, the introduction of these technologies also signals a shift towards greater regulatory oversight in drug distribution. Counterfeit medicines often enter the market through porous borders, illegal distributors, and weak enforcement mechanisms. By leveraging digital tools, NAFDAC can swiftly track the origins of suspect medicines, preventing their spread and holding manufacturers and distributors accountable. This level of monitoring is expected to enhance compliance among pharmaceutical companies and discourage unethical practices. However, its success depends on strict enforcement and collaboration with Law Enforcement Agencies and border control authorities to prevent the inflow of falsified drugs.
Widespread adoption and enforcement are key to success.
For this initiative to be effective, widespread adoption and enforcement will be crucial. Stakeholders across the pharmaceutical industry, including manufacturers, wholesalers, retailers, and healthcare providers, must actively engage with the traceability system. If businesses fail to integrate these technologies, the system may not achieve its intended impact. Public awareness campaigns will also be vital in educating Nigerians on how to use GreenBook to verify their medications. Without proper sensitisation, many consumers may remain unaware of these tools, limiting their effectiveness.
Despite these advancements, challenges remain in tackling the root causes of counterfeit drug circulation. Weak regulatory enforcement, corruption, and gaps in border control continue to enable substandard medicines to enter the market. Criminal networks involved in drug counterfeiting exploit these loopholes, making it difficult for regulators to eliminate fake drugs. Addressing these systemic issues requires sustained government commitment, increased funding for regulatory bodies, and international collaboration to curb the influx of falsified medicines.
Related Article: NAFDAC caution on unregistered condom brand
Ultimately, NAFDAC’s adoption of traceability technology marks a significant step in combating counterfeit medicines in Nigeria. By integrating digital solutions into pharmaceutical regulation, the agency is reinforcing its commitment to safeguarding public health. However, the long-term success of this initiative will rely on effective implementation, industry cooperation, and continued government support. If properly enforced and embraced by all stakeholders, this system has the potential to transform Nigeria’s pharmaceutical sector, ensuring access to safe, high-quality medicines while deterring counterfeit drug networks.